The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Aklief 50 microgram/g Cream

Galderma International S.A.S.PA22743/017/001

Main Information

Trade NameAklief 50 microgram/g Cream
Active SubstancesTrifarotene
Dosage FormCream
Licence HolderGalderma International S.A.S.
Licence NumberPA22743/017/001

Group Information

ATC CodeD10AD06 Trifarotene


Licence Issued21/02/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back